tiprankstipranks
TG Therapeutics (TGTX)
NASDAQ:TGTX

TG Therapeutics (TGTX) Financial Statements

1,617 Followers

TG Therapeutics Financial Overview

TG Therapeutics's market cap is currently ―. The company's EPS TTM is $0.22; its P/E ratio is 96.10; TG Therapeutics is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 63.47M$ 43.97M$ 165.81M$ 16.04M$ 7.80M
Gross Profit$ 58.03M$ 36.12M$ 162.31M$ 16.07M$ 6.95M
EBIT$ -8.39M$ -11.60M$ 136.01M$ -29.53M$ -38.14M
EBITDA$ -8.31M$ -11.50M$ 136.78M$ -28.81M$ -37.55M
Net Income Common Stockholders$ -10.71M$ -14.42M$ 132.30M$ -47.61M$ -39.23M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 209.78M$ 217.51M$ 229.16M$ 144.91M$ 139.71M
Total Assets$ 373.32M$ 329.59M$ 331.07M$ 220.85M$ 197.36M
Total Debt$ 111.67M$ 110.80M$ 109.91M$ 109.02M$ 108.13M
Net Debt$ -98.12M$ -106.71M$ -119.25M$ -35.89M$ -31.58M
Total Liabilities$ 213.21M$ 169.09M$ 166.30M$ 180.40M$ 169.93M
Stockholders Equity$ 160.11M$ 160.50M$ 164.77M$ 40.45M$ -6.30M
Cash Flow-
Free Cash Flow$ -8.21M$ -13.21M$ 83.70M$ -42.48M$ -60.42M
Operating Cash Flow$ -8.21M$ -13.21M$ 83.70M$ -42.48M$ -60.42M
Investing Cash Flow$ -9.26M$ -44.76M$ -30.23M$ 31.00M$ -5.68M
Financing Cash Flow$ 10.00K$ -1.00K$ 421.00K$ 47.05M$ 25.24M
Currency in USD

TG Therapeutics Earnings and Revenue History

TG Therapeutics Debt to Assets

TG Therapeutics Cash Flow

TG Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis